SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Citigroup Upgrades Regeneron Pharmaceuticals to Buy, Raises Price Target to $420

Citigroup upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Neutral to Buy and raises the price target from $340 to $420.

Benzinga · -

Citigroup upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Neutral to Buy and raises the price target from $340 to $420.